We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ‘Won’t Object’ if Drugmakers Leave PCIDs Off Labeling: Guidance
FDA ‘Won’t Object’ if Drugmakers Leave PCIDs Off Labeling: Guidance
December 6, 2011
An FDA final guidance gives deliberately vague advice on whether drugmakers should disclose physical-chemical identifiers (PCIDs) in drug labeling, despite sponsors’ requests for additional clarification.